pericarditis: An inflammatory process affecting the pericardium.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1405 |
4. Check minimum number of eventsNone |
1405 |
5. Include endpointsNone |
1405 |
6. Filter based on genotype QC (FinnGen only) |
1405 |
Control definitions (FinnGen only)
- Control exclude
- I9_OTHHEART
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Pericarditis
based on the number of shared cases.
Similar with more cases:
- Other heart diseases
- Other heart diseases, wide
- Cardiovascular diseases (excluding rheumatic etc)
- Cardiovascular diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 11148 | 3965 | 7055 |
| Only index persons | 8429 | 2937 | 5492 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.17 | 0.11 | 0.20 |
| Only index persons | 0.17 | 0.11 | 0.21 |
| Median age at first event (years) | |||
| Whole population | 52.56 | 60.45 | 47.91 |
| Only index persons | 47.96 | 57.21 | 43.01 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1405 | 520 | 885 |
| Unadjusted period prevalence (%) | 0.31 | 0.18 | 0.39 |
| Median age at first event (years) | 54.08 | 54.38 | 53.90 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1250
- Matched controls
- 12498
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
I30.9
ICD-10 Finland
Acute pericarditis, unspecified
+∞
323.0
647
*
I48
ICD-10 Finland
Atrial fibrillation and flutter
94.8
322.4
350
51
I50.9
ICD-10 Finland
Heart failure, unspecified
100.9
226.2
245
30
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
11.7
219.5
452
575
207
Kela drug reimbursment
Chronic arrhythmias
213.4
195.3
198
11
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
272.6
186.1
186
8
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
8.5
176.0
441
752
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
+∞
175.2
164
*
I31.9
ICD-10 Finland
Disease of pericardium, unspecified
+∞
171.9
161
*
B01AA03
ATC
warfarin; systemic
9.1
152.5
355
521
I30.0
ICD-10 Finland
Acute nonspecific idiopathic pericarditis
+∞
151.2
142
*
C03CA01
ATC
furosemide; systemic
5.3
128.5
482
1316
C07AB07
ATC
bisoprolol; oral
4.3
122.2
682
2751
4209X
ICD-9 Finland
Acute pericarditis, Other and unspecified acute pericarditis[PERICARDITIS ALIA DEFINITA SEU NUD]
+∞
110.0
104
*
I30.8
ICD-10 Finland
Other forms of acute pericarditis
+∞
107.9
102
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.8
105.8
690
3058
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
5.1
104.4
390
1020
I50.0
ICD-10 Finland
Congestive heart failure
111.7
103.9
112
11
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
186.8
99.9
103
6
I30.1
ICD-10 Finland
Infective pericarditis
+∞
98.2
93
*
TFP20
NOMESCO Finland
Cardiodefibrillation
87.2
93.7
104
13
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
5.3
91.9
319
755
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
203.0
91.6
94
5
I35.0
ICD-10 Finland
Aortic (valve) stenosis
65.8
89.3
103
17
R07.4
ICD-10 Finland
Chest pain, unspecified
3.8
86.4
470
1708
B01AF02
ATC
apixaban; oral
17.3
83.5
135
87
I50.1
ICD-10 Finland
Left ventricular failure
418.0
79.8
79
*
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
73.5
78.5
89
13
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
11.1
76.9
152
154
XF400
NOMESCO Finland
ECG with 12 standard connections
4.2
72.5
321
950
I40.9
ICD-10 Finland
Acute myocarditis, unspecified
738.8
71.9
70
*
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
157.1
70.8
74
5
XF404
NOMESCO Finland
Ambulatory ECG
9.7
69.9
148
170
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
187.9
68.8
71
*
R06.0
ICD-10 Finland
Dyspnoea
3.6
68.4
372
1307
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
243.1
67.9
69
*
C01AA05
ATC
digoxin; systemic
14.2
67.6
118
91
H02AB06
ATC
prednisolone; systemic
2.8
66.5
674
3642
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.3
66.1
418
1641
I25.1
ICD-10 Finland
Atherosclerotic heart disease
3.6
64.4
351
1225
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.8
60.9
225
548
42009
ICD-8 Finland
Acute pericarditis, nonrheumatic, Unspecified
+∞
59.9
57
*
R50.9
ICD-10 Finland
Fever, unspecified
3.9
57.8
270
820
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
305.6
57.8
58
*
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
7.3
56.9
144
219
I51.4
ICD-10 Finland
Myocarditis, unspecified
+∞
56.7
54
*
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
10.0
55.7
115
125
FEB10
NOMESCO Finland
Decompression and drainage of pericardium
294.1
55.7
56
*
I34.00
ICD-10 Finland
Mitral (valve) incompetence NOS or of specified cause, except rheumatic
+∞
55.6
53
*
C03DA01
ATC
spironolactone; oral
5.7
54.7
168
330
K78
ICPC
Atrial fibrillation/flutter
19.7
54.3
83
45
I34.1
ICD-10 Finland
Mitral (valve) prolapse
103.1
54.3
59
6
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
550.6
53.9
53
*
Z95.2
ICD-10 Finland
Presence of prosthetic heart valve
277.0
52.5
53
*
I49.5
ICD-10 Finland
Sick sinus syndrome
271.4
51.5
52
*
A02BC02
ATC
pantoprazole; systemic
2.5
50.9
836
5569
AN1
HP
Coronary angiography
4.4
48.9
193
496
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
5.3
48.5
158
331
201
Kela drug reimbursment
Chronic cardiac insufficiency
12.7
48.4
88
74
I44.2
ICD-10 Finland
Atrioventricular block, complete
+∞
48.2
46
*
TPH04
NOMESCO Finland
Cathetrisation of vein
3.1
47.5
319
1258
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
12.7
47.4
86
72
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
3.0
47.0
335
1374
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
6.5
46.6
128
217
WX892
NOMESCO Finland
Monitored bed care
5.4
46.5
149
306
I47.1
ICD-10 Finland
Supraventricular tachycardia
85.0
44.2
49
6
C01BD01
ATC
amiodarone; systemic
121.9
44.0
47
*
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
10.5
43.7
87
88
42007
ICD-8 Finland
Acute pericarditis, nonrheumatic, Suspecta
+∞
43.0
41
*
L04AX01
ATC
azathioprine; systemic
6.9
42.9
111
173
I31.3
ICD-10 Finland
Pericardial effusion (noninflammatory)
+∞
40.8
39
*
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
4.1
39.8
169
461
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
2.8
37.0
274
1133
I35.2
ICD-10 Finland
Aortic (valve) stenosis with insufficiency
82.6
36.0
40
5
FM1DG
NOMESCO Finland
Very extensive MRI examination of heart with high intesity magnet
82.6
36.0
40
5
I49.3
ICD-10 Finland
Ventricular premature depolarization
10.5
35.9
71
71
J01MA12
ATC
levofloxacin; systemic
2.7
35.5
288
1254
C07AB02
ATC
metoprolol; systemic
2.7
35.3
276
1176
I97.0
ICD-10 Finland
Postcardiotomy syndrome
97.9
34.9
38
*
4273A
ICD-9 Finland
Cardiac dysrhythmias, Atrial fibrillation and flutter
+∞
34.5
33
*
C01BC04
ATC
flecainide; systemic
78.4
34.0
38
5
FPE00
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with ventricular electrode
+∞
33.5
32
*
I42.0
ICD-10 Finland
Dilated cardiomyopathy
+∞
33.5
32
*
H02AB07
ATC
prednisone; oral
2.9
33.1
228
894
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
63.4
32.2
37
6
I42.9
ICD-10 Finland
Cardiomyopathy, unspecified
324.9
32.0
32
*
I20.09
ICD-10 Finland
Unstable angina
5.2
31.6
102
210
FMD10
NOMESCO Finland
Replacement of aortic valve using biological prosthesis
+∞
31.4
30
*
I31.8
ICD-10 Finland
Other specified diseases of pericardium
+∞
31.4
30
*
TFP34
NOMESCO Finland
Electrophysiological investigation
320.4
31.0
31
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.9
30.9
106
233
C01DA14
ATC
isosorbide mononitrate; oral
2.8
30.5
213
840
XF402
NOMESCO Finland
ECG with work load test
3.4
29.8
153
486
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.9
29.7
205
801
PD5BD
NOMESCO Finland
Extensive CT of aorta
12.2
29.6
54
46
I48.1
ICD-10 Finland
Persistent atrial fibrillation
+∞
29.3
28
*
R4110
NOMESCO Finland
Physiotherapy
2.3
29.3
348
1826
81
HP
Angiography of the heart and coronary arteries
4.3
29.1
113
282
I47.2
ICD-10 Finland
Ventricular tachycardia
105.9
28.8
31
*
B01AB05
ATC
enoxaparin; parenteral
2.2
28.7
371
2020
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
6.2
28.4
78
132
WX872
NOMESCO Finland
Intensive care
5.4
27.8
86
168
C09AA05
ATC
ramipril; oral
2.3
27.4
305
1545
4209A
ICD-9 Finland
Acute pericarditis, Other and unspecified acute pericarditis[PERICARDITIS ACUTA INFECTIOSA]
+∞
27.2
26
*
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
22.3
27.1
39
18
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.1
26.7
380
2145
P01BA02
ATC
hydroxychloroquine; oral
3.4
26.4
137
437
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.5
26.4
129
393
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.5
26.1
233
1052
C07AA07
ATC
sotalol; systemic
8.4
26.1
58
72
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.8
25.7
113
315
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.6
25.5
92
213
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
3.6
25.1
120
359
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
3.2
24.5
138
467
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.8
24.1
170
667
GD1AD
NOMESCO Finland
Thorax CT examination
4.9
24.1
81
174
FKB10
NOMESCO Finland
Annuloplasty of mitral valve for insufficiency using ring
+∞
24.0
23
*
I36.1
ICD-10 Finland
Nonrheumatic tricuspid (valve) insufficiency
+∞
24.0
23
*
XFE00
NOMESCO Finland
Epicardial ultrasonography
10.8
23.9
46
44
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
23.9
344
1936
J01FF01
ATC
clindamycin; systemic
2.1
23.8
335
1864
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
5.0
23.8
78
163
L04AA06
ATC
mycophenolic acid; systemic
8.5
23.3
51
62
J01MA14
ATC
moxifloxacin; systemic
3.0
23.0
140
500
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
2.2
22.9
258
1301
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.8
22.8
99
273
I32.8*M05.3
ICD-10 Finland
Pericarditis (in) rheumatoid
+∞
21.9
21
*
I33.0
ICD-10 Finland
Acute and subacute infective endocarditis
+∞
21.9
21
*
I44.1
ICD-10 Finland
Atrioventricular block, second degree
117.0
21.6
23
*
I11.0
ICD-10 Finland
Hypertensive heart disease with (congestive) heart failure
117.0
21.6
23
*
TPH07
NOMESCO Finland
Cathetrisation of artery
2.8
21.4
144
548
N02BE01
ATC
paracetamol; systemic, rectal
1.9
21.2
993
8313
I25.2
ICD-10 Finland
Old myocardial infarction
3.6
21.1
100
297
I20.99
ICD-10 Finland
Angina pectoris, unspecified
3.8
21.0
93
261
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.8
21.0
586
4138
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
7.9
20.9
48
63
FMD00
NOMESCO Finland
Replacement of aortic valve using mechanical prosthesis
+∞
20.9
20
*
N02AX02
ATC
tramadol; systemic, rectal
1.8
20.8
513
3472
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.4
20.8
186
834
I71.2
ICD-10 Finland
Thoracic aortic aneurysm, without mention of rupture
8.0
20.4
46
59
XF640
NOMESCO Finland
NA
9.2
20.2
42
47
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
20.0
323
1881
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.4
20.0
195
910
R07.3
ICD-10 Finland
Other chest pain
2.9
19.9
129
480
M04AA01
ATC
allopurinol; systemic
2.5
19.9
170
743
TK800
NOMESCO Finland
Hemodialysis
7.5
19.9
47
65
42000
ICD-8 Finland
Acute pericarditis, nonrheumatic, Pleuropericarditis
+∞
19.8
19
*
I48.2
ICD-10 Finland
Chronic atrial fibrillation
+∞
19.8
19
*
FPE30
NOMESCO Finland
Replacement of transvenous cardiac pacemaker pulse generator
106.7
19.6
21
*
C08DA01
ATC
verapamil; systemic
6.4
19.4
51
82
J01FA06
ATC
roxithromycin; oral
1.8
19.3
459
3054
A02BC01
ATC
omeprazole; systemic
1.9
19.1
343
2069
I50
ICD-10 Finland
Heart failure
14.2
19.1
32
23
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
7.5
19.1
45
62
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.8
19.0
454
3019
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
18.9
385
2428
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.0
18.9
78
206
127
Kela drug reimbursment
Transplant complication
8.2
18.8
42
53
I49.0
ICD-10 Finland
Ventricular fibrillation and flutter
+∞
18.8
18
*
I10
ICD-10 Finland
Essential (primary) hypertension
1.7
18.4
654
4894
TGC00
NOMESCO Finland
Bronchial lavation
5.9
18.3
51
89
J01DB01
ATC
cefalexin; oral
1.8
18.3
939
7837
AS4
HP
Physiological pacemaker insertion DDD (R)
+∞
17.7
17
*
J01CA04
ATC
amoxicillin; systemic
1.8
17.7
913
7578
FNA01
NOMESCO Finland
Anastomosis to coronary artery from internal mammary artery, one distal anastamosis
3.8
17.5
75
205
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.7
17.1
77
220
R04.0
ICD-10 Finland
Epistaxis
3.2
17.0
90
292
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
11.3
16.8
31
28
TFP35
NOMESCO Finland
Electroanatomical mapping
+∞
16.7
16
*
I32.8*M32.1
ICD-10 Finland
Pericarditis (in) systemic lupus erythematosus
+∞
16.7
16
*
AA1AD
NOMESCO Finland
CT of head and brain
2.0
16.7
259
1473
K83
ICPC
Heart valve disease NOS
91.3
16.6
18
*
A46
ICD-10 Finland
Erysipelas
2.3
16.5
168
796
Z49.1
ICD-10 Finland
Extracorporeal dialysis
10.9
16.5
31
29
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.7
16.5
119
471
R03AC02
ATC
salbutamol; inhalant
1.7
16.5
562
4109
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.3
16.4
84
266
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
3.5
16.0
75
222
R02
ICPC
Shortness of breath/dyspnoea
2.5
15.9
131
559
A41.9
ICD-10 Finland
Sepsis, unspecified
4.3
15.9
59
142
I20.90
ICD-10 Finland
Angina pectoris, unspecified
4.2
15.9
60
147
K84
ICPC
Heart disease other
8.5
15.8
34
41
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.8
15.8
327
2055
C10AX09
ATC
ezetimibe; oral
2.4
15.7
139
618
AB2
HP
AVR bio, stent
+∞
15.7
15
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
15.6
445
3076
SPAT1097
SPAT
Recording of ECG
2.2
15.4
170
839
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.7
15.4
497
3559
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.9
15.3
93
332
C10AA05
ATC
atorvastatin; oral
1.7
15.1
424
2911
61
HP
Catheterization and pressure measurement of the left side of the heart
6.5
15.1
39
62
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
14.8
217
1204
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.6
14.6
109
441
TFP44
NOMESCO Finland
Ablation treatment of typical atrial flutter
+∞
14.6
14
*
AQ1
HP
Conventional electrophysiological examination
+∞
14.6
14
*
A12AA04
ATC
calcium carbonate; oral
8.6
14.5
31
37
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
3.4
14.5
72
223
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.5
14.5
122
526
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.2
14.4
161
796
A11
ICPC
Chest pain NOS
2.9
14.4
92
338
ZX120
NOMESCO Finland
Intravenous
2.5
14.4
116
489
A02BC05
ATC
esomeprazole; systemic
1.7
14.3
439
3082
PH1AC
NOMESCO Finland
Flebography of over extremity with X-ray
43.0
14.1
17
*
A11CC03
ATC
alfacalcidol; systemic
6.0
14.0
38
65
205
Kela drug reimbursment
Chronic hypertension
1.7
13.9
320
2064
R00.2
ICD-10 Finland
Palpitations
3.2
13.8
73
237
D64.9
ICD-10 Finland
Anaemia, unspecified
2.4
13.8
118
511
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.3
13.8
131
599
I34.0
ICD-10 Finland
Mitral (valve) insufficiency
24.1
13.8
19
8
B01AC04
ATC
clopidogrel; oral
2.0
13.6
178
944
342
Kela drug reimbursment
Dronedarone
+∞
13.6
13
*
TFP46
NOMESCO Finland
Ablation treatment of atrial fibrillation
+∞
13.6
13
*
FE1AT
NOMESCO Finland
Pericardial puncture with ultrasound guidance
+∞
13.6
13
*
FE2AT
NOMESCO Finland
Pericardial cathetrisation with ultrasound guidance
+∞
13.6
13
*
42008
ICD-8 Finland
Acute pericarditis, nonrheumatic, Alii definiti
+∞
13.6
13
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
13.5
183
981
I20.00
ICD-10 Finland
Unstable angina
4.4
13.4
48
112
A12BA01
ATC
potassium chloride; oral
3.9
13.4
55
146
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.8
13.3
262
1604
P01AB01
ATC
metronidazole; oral, rectal
1.6
13.1
414
2909
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
2.9
13.1
80
286
B01AE07
ATC
dabigatran etexilate; oral
5.3
13.1
39
75
WX002
NOMESCO Finland
Sedation and analgesia
1.9
13.1
221
1288
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
5.8
13.0
36
63
R00.0
ICD-10 Finland
Tachycardia, unspecified
4.1
13.0
50
125
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.5
13.0
107
455
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.7
12.9
292
1868
G47.3
ICD-10 Finland
Sleep apnoea
1.8
12.9
241
1449
WX402
NOMESCO Finland
General anaesthesia
2.0
12.9
182
990
TFP00
NOMESCO Finland
Temporary use of transvenous or epicardial pacemaker
50.5
12.9
15
*
Z94.0
ICD-10 Finland
Kidney transplant status
8.2
12.8
28
35
N18.8
ICD-10 Finland
Other chronic renal failure
4.9
12.7
41
86
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.8
12.7
80
293
N02AJ06
ATC
codeine and paracetamol; systemic
1.6
12.7
388
2701
XF600
NOMESCO Finland
Bloodpressure measurement
2.8
12.7
83
311
C08CA01
ATC
amlodipine; oral
1.6
12.6
391
2731
TFP30
NOMESCO Finland
Cathetric examination for cardiac arrythmia
70.6
12.6
14
*
B03XA02
ATC
darbepoetin alfa; parenteral
6.0
12.6
34
58
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.6
12.6
93
375
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
11.1
12.5
23
21
FKC50
NOMESCO Finland
Repair of mitral valve for insufficiency using prosthetic chord
+∞
12.5
12
*
I48.3
ICD-10 Finland
Typical atrial flutter
+∞
12.5
12
*
C01BD07
ATC
dronedarone; oral
+∞
12.5
12
*
AC4
HP
MVP
+∞
12.5
12
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.6
12.5
358
2448
J01DA01
ATC
[U] cefalexin; systemic
1.5
12.5
700
5646
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.2
12.4
127
604
I21.99
ICD-10 Finland
Myocardial infarction (acute) UNS unspecified coronary artery status
4.7
12.4
41
89
L04AD01
ATC
ciclosporin; systemic
5.1
12.4
38
76
N02AA05
ATC
oxycodone; systemic
2.0
12.3
176
960
R42
ICD-10 Finland
Dizziness and giddiness
1.8
12.3
225
1342
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
2.3
12.1
115
526
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.4
12.1
108
482
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.9
12.0
49
130
GD2SN
NOMESCO Finland
Lung ventilation SPECT
21.5
12.0
17
8
UJF32
NOMESCO Finland
Coloscopy
1.7
11.8
270
1726
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.1
11.7
130
642
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.4
11.7
42
99
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.6
11.6
85
341
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.2
11.6
117
551
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.3
11.6
114
530
J01AA02
ATC
doxycycline; systemic
1.6
11.6
871
7451
J45.9
ICD-10 Finland
Asthma, unspecified
1.9
11.6
183
1037
I25.5
ICD-10 Finland
Ischaemic cardiomyopathy
11.2
11.6
21
19
J01MA02
ATC
ciprofloxacin; systemic
1.6
11.5
437
3195
103
Kela drug reimbursment
Diabetes, insulin-treated
1.7
11.5
301
1999
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
9.3
11.5
23
25
73
HP
Initial pacemaker installation
+∞
11.5
11
*
72
HP
Catheter ablation of arrhythmia
+∞
11.5
11
*
289
Kela drug reimbursment
Combination product containing sacubitril and valsartan
+∞
11.5
11
*
AS2
HP
Ventricular pacemaker insertion VVI (R)
+∞
11.5
11
*
42798
ICD-8 Finland
Symptomatic heart disease, Alia arrhytmia definita
+∞
11.5
11
*
I32.8
ICD-10 Finland
Pericarditis in other diseases classified elsewhere
+∞
11.5
11
*
I46.0
ICD-10 Finland
Cardiac arrest with successful resuscitation
+∞
11.5
11
*
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
7.0
11.4
27
39
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
3.7
11.3
48
132
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.1
11.3
135
688
XF409
NOMESCO Finland
Other special ECG
35.3
11.3
14
*
I11.9
ICD-10 Finland
Hypertensive heart disease without (congestive) heart failure
3.9
11.1
45
119
R53
ICD-10 Finland
Malaise and fatigue
1.8
11.1
205
1225
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
6.5
11.1
28
44
N05CF01
ATC
zopiclone; oral
1.6
11.1
352
2461
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
5.6
11.1
31
56
R00.1
ICD-10 Finland
Bradycardia, unspecified
5.6
11.1
31
56
K80
ICPC
Cardiac arrhythmia NOS
3.0
11.0
63
217
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
3.1
10.9
59
196
C09CA01
ATC
losartan; oral
1.7
10.9
259
1673
SPAT1263
SPAT
Sampling
1.5
10.8
427
3141
J86.9
ICD-10 Finland
Pyothorax without fistula
10.7
10.8
20
19
GD1UN
NOMESCO Finland
Lung circulation SPECT
18.0
10.7
16
9
WW200
NOMESCO Finland
Immunization
4.2
10.7
39
94
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
3.1
10.7
58
194
SPAT1254
SPAT
Administration of medicine
1.9
10.7
156
860
I35.9
ICD-10 Finland
Aortic valve disorder, unspecified
60.5
10.6
12
*
I42.2
ICD-10 Finland
Other hypertrophic cardiomyopathy
60.5
10.6
12
*
FNC10
NOMESCO Finland
Aorto-coronary venous bypass with single distal anastomosis
6.6
10.5
26
40
I31.1
ICD-10 Finland
Chronic constrictive pericarditis
+∞
10.4
10
*
42792
ICD-8 Finland
Symptomatic heart disease, Fibrillatio auricularis
+∞
10.4
10
*
I40.0
ICD-10 Finland
Infective myocarditis
+∞
10.4
10
*
I21.41
ICD-10 Finland
Acute subendocardial infarction stenosed coronary artery
3.1
10.4
55
181
N18.0
ICD-10 Finland
End-stage renal disease
8.3
10.3
22
27
137
Kela drug reimbursment
Uraemia requiring dialysis
8.3
10.3
22
27
R07.1
ICD-10 Finland
Chest pain on breathing
5.6
10.3
29
53
K99
ICPC
Cardiovascular disease other
5.1
10.2
31
62
I49.4
ICD-10 Finland
Other and unspecified premature depolarization
6.3
10.2
26
42
ZXA05
NOMESCO Finland
Left side
1.6
10.2
276
1844
A02BC03
ATC
lansoprazole; oral
1.6
10.1
309
2129
JN4BD
NOMESCO Finland
Extensive body CT
2.0
10.1
140
753
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
10.1
221
1388
M05BA04
ATC
alendronic acid; oral
2.3
10.0
92
418
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
3.0
9.9
57
198
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.8
9.9
196
1198
I20.01
ICD-10 Finland
Unstable angina
4.0
9.9
38
97
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.1
9.8
114
575
7865A
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Chest pain
4.6
9.8
33
74
R60.0
ICD-10 Finland
Localized oedema
2.1
9.7
111
555
J94.8
ICD-10 Finland
Other specified pleural conditions
5.4
9.7
28
53
R05
ICD-10 Finland
Cough
1.7
9.7
197
1211
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
7.9
9.6
21
27
H02AB04
ATC
methylprednisolone; systemic
1.9
9.6
155
884
TK810
NOMESCO Finland
Hemofiltration
11.5
9.6
17
15
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.9
9.5
145
808
SPAT1301
SPAT
No procedures
1.6
9.5
323
2279
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.8
9.5
180
1082
N03AX16
ATC
pregabalin; oral
1.7
9.5
240
1569
I20.89
ICD-10 Finland
Other angina pectoris unspecified coronary artery status
3.1
9.4
51
171
S97
ICPC
Chronic ulcer skin
2.8
9.4
59
216
B01AF01
ATC
rivaroxaban; oral
2.2
9.4
97
462
V03AE02
ATC
sevelamer; oral
17.7
9.4
14
8
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.1
9.4
102
499
C09DX04
ATC
valsartan and sacubitril; oral
+∞
9.4
9
*
I32.0
ICD-10 Finland
Pericarditis in bacterial diseases classified elsewhere
+∞
9.4
9
*
I32.8*N18.8
ICD-10 Finland
Pericarditis (in) uraemic
+∞
9.4
9
*
42700
ICD-8 Finland
Symptomatic heart disease, Congestive heart failure
+∞
9.4
9
*
I42.8
ICD-10 Finland
Other cardiomyopathies
+∞
9.4
9
*
381
Kela drug reimbursment
Combination product containing sacubitril and valsartan
+∞
9.4
9
*
TFC25
NOMESCO Finland
Transseptal catheterisation of left atrium or ventricle
+∞
9.4
9
*
FME20
NOMESCO Finland
Transvenous aortic valve replacement via femoral artery
+∞
9.4
9
*
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
4.1
9.4
35
87
JN4AD
NOMESCO Finland
Body CT examination
2.2
9.4
93
438
FL1AC
NOMESCO Finland
Left cardioangiography
5.9
9.4
25
43
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
4.0
9.4
36
92
FC1AC
NOMESCO Finland
Angiography of thoracal aortta
21.9
9.4
13
6
M10.9
ICD-10 Finland
Gout, unspecified
2.5
9.3
70
287
I49.1
ICD-10 Finland
Atrial premature depolarization
6.5
9.3
23
36
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
7.3
9.2
21
29
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
4.3
9.2
33
79
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.2
9.2
93
440
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.2
9.2
93
440
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
6.8
9.1
22
33
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.8
9.1
161
945
A10AE04
ATC
insulin glargine; parenteral
2.1
9.1
107
542
FN1YT
NOMESCO Finland
Percutaneous insertion of coronary artery stent
2.7
9.1
61
232
B05DB
ATC
Hypertonic solutions
11.6
9.1
16
14
N05BA04
ATC
oxazepam; oral
1.6
9.0
248
1660
11
HP
Coronary artery bypass surgery
3.8
9.0
36
96
I71.9
ICD-10 Finland
Aortic aneurysm of unspecified site, without mention of rupture
7.5
8.9
20
27
FM1CG
NOMESCO Finland
Extensive examination of hear with high intensity magnet
18.7
8.9
13
7
Q23.11
ICD-10 Finland
Bicuspid aortic valve
18.7
8.9
13
7
B99
ICD-10 Finland
Other and unspecified infectious diseases
4.7
8.9
29
63
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.7
8.9
198
1251
L04AA13
ATC
leflunomide; oral
3.6
8.9
38
107
I47.9
ICD-10 Finland
Paroxysmal tachycardia, unspecified
12.6
8.9
15
12
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.6
8.8
256
1735
R03BB04
ATC
tiotropium bromide; inhalant
2.0
8.8
106
541
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
2.2
8.7
83
383
FM1BD
NOMESCO Finland
Extensive CT of heart
50.3
8.7
10
*
62
HP
Catheterization and pressure measurement of the right side of the heart
50.3
8.7
10
*
FN1CC
NOMESCO Finland
Very extensive angiography of heart and/or coronary arteries
5.8
8.6
23
40
X59
ICD-10 Finland
Exposure to unspecified factor
1.7
8.6
192
1211
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
11.7
8.6
15
13
I21.90
ICD-10 Finland
Myocardial infarction (acute) UNS no detected stenosis of the coronary artery
4.8
8.6
27
57
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
3.2
8.6
44
143
GD1LA
NOMESCO Finland
GD
16.4
8.6
13
8
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.1
8.5
91
441
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.4
8.5
40
122
FWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels
20.2
8.5
12
6
C09AA02
ATC
enalapril; systemic
1.6
8.4
213
1392
C01BA01
ATC
quinidine; oral
90.6
8.4
9
*
7100A
ICD-9 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
90.6
8.4
9
*
I34.9
ICD-10 Finland
Nonrheumatic mitral valve disorder, unspecified
90.6
8.4
9
*
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
4.9
8.4
26
54
FN2BA
NOMESCO Finland
Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)
2.5
8.4
62
253
SPAT1104
SPAT
Monitoring of emergency patient
2.4
8.4
70
303
T90
ICPC
Diabetes non-insulin dependent
1.6
8.4
237
1594
FKC20
NOMESCO Finland
Plastic repair of mitral valve leaflet for insufficiency
+∞
8.3
8
*
4276B
ICD-9 Finland
Cardiac dysrhythmias, Premature beats[EXTRASYSTOLIA VENTRICULARIS]
+∞
8.3
8
*
FCA70
NOMESCO Finland
Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of biological valve prosthesis and tube graft
+∞
8.3
8
*
TFJ02
NOMESCO Finland
Muscle biopsy of heart
+∞
8.3
8
*
FJA10
NOMESCO Finland
Transvenous biopsy of right ventricle
+∞
8.3
8
*
TFC20
NOMESCO Finland
Catheterisation of both sides of heart
+∞
8.3
8
*
TFP40
NOMESCO Finland
Ablation treatment for a-v node re-entry activation
+∞
8.3
8
*
I44.3
ICD-10 Finland
Other and unspecified atrioventricular block
+∞
8.3
8
*
42299
ICD-8 Finland
Acute myocarditis, Unspecified
+∞
8.3
8
*
AB1
HP
AVR mechanical
+∞
8.3
8
*
I42.1
ICD-10 Finland
Obstructive hypertrophic cardiomyopathy
+∞
8.3
8
*
FEA00
NOMESCO Finland
Closed external drainage of pericardium
+∞
8.3
8
*
I31.2
ICD-10 Finland
Haemopericardium, not elsewhere classified
+∞
8.3
8
*
B05DA
ATC
Isotonic solutions
8.6
8.3
17
20
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.4
8.2
67
288
C07AG02
ATC
carvedilol; oral
2.5
8.2
63
261
B34.9
ICD-10 Finland
Viral infection, unspecified
3.5
8.2
36
104
R03AK08
ATC
formoterol and beclometasone; inhalant
3.2
8.2
40
126
A02BA02
ATC
ranitidine; systemic
1.6
8.1
210
1380
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
3.0
8.1
44
149
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.7
8.1
176
1103
B01AC06
ATC
acetylsalicylic acid; oral (platelet aggregation inhibitors excl. heparin)
2.8
8.0
48
173
SPAT1229
SPAT
Assessment of need for aid
2.2
8.0
81
385
M32.0
ICD-10 Finland
Drug-induced systemic lupus erythematosus
22.2
8.0
11
5
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.1
8.0
42
139
AA1
HP
Conventional CABG
4.6
8.0
26
57
C10AA01
ATC
simvastatin; oral
1.4
8.0
452
3535
R51.80
ICD-10 Finland
Headache
1.8
8.0
134
772
UJF30
NOMESCO Finland
Ileoscopy through colon
2.0
8.0
102
532
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
7.3
8.0
18
25
3AC01
NOMESCO Finland
NA
7.3
8.0
18
25
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
2.7
7.9
51
192
B01AF03
ATC
edoxaban; oral
13.1
7.9
13
10
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.9
7.9
46
163
SPAT1262
SPAT
Handing over of treatment supplies
1.6
7.9
194
1258
I49.8
ICD-10 Finland
Other specified cardiac arrhythmias
5.4
7.8
22
41
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.3
7.8
38
119
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
10.9
7.8
14
13
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
3.9
7.8
30
78
E0000UV
ATC
NA
1.5
7.7
384
2925
71
HP
Electrophysiological Special Examination
45.2
7.7
9
*
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
45.2
7.7
9
*
M54.6
ICD-10 Finland
Pain in thoracic spine
2.3
7.7
68
302
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.7
7.6
148
896
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
18.5
7.6
11
6
Z50.0
ICD-10 Finland
Cardiac rehabilitation
6.7
7.6
18
27
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.9
7.6
115
643
L04AA01
ATC
[U] ciclosporin; systemic
4.5
7.6
25
56
Z95.8
ICD-10 Finland
Presence of other cardiac and vascular implants and grafts
25.2
7.6
10
*
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.1
7.6
80
389
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.6
7.5
52
204
C08DB01
ATC
diltiazem; oral
2.5
7.5
56
230
R4190
NOMESCO Finland
Nutritional therapy
3.0
7.5
41
141
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
2.6
7.4
52
206
H02AB09
ATC
hydrocortisone; systemic
3.7
7.4
30
82
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.7
7.4
48
183
B01AC24
ATC
ticagrelor; oral
2.8
7.3
44
160
R55
ICD-10 Finland
Syncope and collapse
1.9
7.3
103
560
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
10.9
7.3
13
12
FPG96
NOMESCO Finland
Other implantation of permanent cardioverter-defibrillator
+∞
7.3
7
*
FPE40
NOMESCO Finland
Replacement of transvenous cardiac pacemaker electrode
+∞
7.3
7
*
FKC60
NOMESCO Finland
Resection and reconstruction of leaflet of mitral valve for insufficiency
+∞
7.3
7
*
FPH10
NOMESCO Finland
Open removal of transvenous cardiac pacemaker or cardioverter-defibrillator
+∞
7.3
7
*
I33.9
ICD-10 Finland
Acute endocarditis, unspecified
+∞
7.3
7
*
4270A
ICD-9 Finland
Cardiac dysrhythmias, Paroxysmal supraventricular tachycardia
+∞
7.3
7
*
Z95.3
ICD-10 Finland
Presence of xenogenic heart valve
+∞
7.3
7
*
ATX
HP
Other pacemaker replacement or related action, such as cord removal or replacement
+∞
7.3
7
*
4220A
ICD-9 Finland
Acute myocarditis in diseases classified elsewhere
+∞
7.3
7
*
TFE00
NOMESCO Finland
Pericardiocentesis
+∞
7.3
7
*
I38
ICD-10 Finland
Endocarditis, valve unspecified
+∞
7.3
7
*
FPJ04
NOMESCO Finland
Revision of pacemaker generator with atrial and ventricular electrodes
+∞
7.3
7
*
K77
ICPC
Heart failure
9.4
7.3
14
15
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.1
7.3
80
395
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.1
7.3
82
408
C02AC05
ATC
moxonidine; oral
2.6
7.3
50
195
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
15.8
7.2
11
7
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
5.8
7.2
19
33
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
5.8
7.2
19
33
TKC20
NOMESCO Finland
Catheterisation of bladder
2.1
7.2
80
397
M10
ICD-10 Finland
Gout
2.6
7.2
48
186
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.0
7.2
84
425
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.6
7.2
172
1106
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.1
7.1
37
123
B01AB10
ATC
tinzaparin; parenteral
2.2
7.1
70
331
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
2.4
7.1
56
237
M10.0
ICD-10 Finland
Idiopathic gout
3.2
7.1
35
112
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
12.1
7.1
12
10
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.1
7.1
81
407
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
7.1
644
5444
FNC20
NOMESCO Finland
Aorto-coronary venous bypass with two distal anastomoses
3.9
7.0
27
71
J01CF05
ATC
flucloxacillin; systemic
2.8
7.0
41
147
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
3.0
6.9
37
125
R11
ICD-10 Finland
Nausea and vomiting
2.1
6.9
76
377
Q21.10
ICD-10 Finland
Persistent ostium secundum
13.9
6.9
11
8
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.0
6.9
84
434
N30.0
ICD-10 Finland
Acute cystitis
1.8
6.9
118
689
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.6
6.9
163
1044
PD5AD
NOMESCO Finland
CT of aorta
4.8
6.9
21
44
JN3AD
NOMESCO Finland
Abdominal CT examination
2.1
6.8
79
397
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.8
6.8
119
696
A06AD11
ATC
lactulose; oral
1.7
6.8
155
982
J94.9
ICD-10 Finland
Pleural condition, unspecified
11.0
6.8
12
11
40199
ICD-8 Finland
Essential benign hypertension
4.5
6.8
22
49
J01FA10
ATC
azithromycin; systemic
1.4
6.8
563
4673
J01FA01
ATC
erythromycin; systemic
1.7
6.8
129
778
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.2
6.7
67
317
I20.80
ICD-10 Finland
Other angina pectoris no detected stenosis of coronary artery
4.7
6.7
21
45
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
7.2
6.7
15
21
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
6.7
187
1252
WX110
NOMESCO Finland
Local anesthesy
1.4
6.7
708
6113
RS221
NOMESCO Finland
NA
3.8
6.7
26
69
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
4.5
6.7
22
50
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.0
6.6
80
412
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.8
6.6
105
596
L28
ICPC
Limited function/disability (L)
1.7
6.6
150
951
I44.7
ICD-10 Finland
Left bundle-branch block, unspecified
12.3
6.6
11
9
FM2CE
NOMESCO Finland
NA
12.3
6.6
11
9
I45.0
ICD-10 Finland
Right fascicular block
12.3
6.6
11
9
KA1AE
NOMESCO Finland
Kidney ultrasound examination
3.2
6.6
32
102
C07AB03
ATC
atenolol; systemic
2.2
6.6
61
281
J45.1
ICD-10 Finland
Nonallergic asthma
2.1
6.5
70
341
AN4
HP
Balloon angioplasty and drug eluding stent
2.8
6.5
39
142
A10BA02
ATC
metformin; oral
1.5
6.5
278
2042
N06AX11
ATC
mirtazapine; oral
1.4
6.5
303
2265
C09AA01
ATC
captopril; oral
4.0
6.5
24
61
I30
ICD-10 Finland
Acute pericarditis
70.2
6.4
7
*
ZSF00
NOMESCO Finland
Procedure related to previous procedure classified in chapter F
70.2
6.4
7
*
FEC00
NOMESCO Finland
Pericardiopleurostomy
70.2
6.4
7
*
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.1
6.4
65
311
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.1
6.4
67
324
R03BA05
ATC
fluticasone; inhalant
1.6
6.4
172
1139
C08CA05
ATC
nifedipine; systemic
2.0
6.4
74
375
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.4
6.4
52
225
K57.9
ICD-10 Finland
Diverticular disease of intestine, part unspecified, without perforation or abscess
3.3
6.4
29
88
C08CA02
ATC
felodipine; oral
1.9
6.4
94
523
4019X
ICD-9 Finland
Essential hypertension, Unspecified
3.0
6.4
34
116
K86.3
ICD-10 Finland
Pseudocyst of pancreas
8.2
6.3
13
16
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.2
6.3
59
271
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
3.0
6.3
33
111
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.7
6.3
39
146
FN1BB
NOMESCO Finland
Contrast angiography of heart and/or coronary arteries after bypass surgery
9.3
6.3
12
13
A28
ICPC
Limited function/disability NOS
1.7
6.3
137
859
FKD00
NOMESCO Finland
Replacement of mitral valve using mechanical prosthesis
+∞
6.3
6
*
42099
ICD-8 Finland
NA
+∞
6.3
6
*
FPG32
NOMESCO Finland
Implantation of cardioverter-defibrillator with atrial and ventricular electrodes
+∞
6.3
6
*
Z95.4
ICD-10 Finland
Presence of other heart-valve replacement
+∞
6.3
6
*
FEE00
NOMESCO Finland
Biopsy of pericardium
+∞
6.3
6
*
XF614
NOMESCO Finland
Measurement of pulmonary artery pressure
+∞
6.3
6
*
FEC10
NOMESCO Finland
Pericardioperitoneostomy
+∞
6.3
6
*
FKD10
NOMESCO Finland
Replacement of mitral valve using biological prosthesis
+∞
6.3
6
*
I20
ICD-10 Finland
Angina pectoris
4.3
6.2
21
49
I45.9
ICD-10 Finland
Conduction disorder, unspecified
26.8
6.2
8
*
Z94.1
ICD-10 Finland
Heart transplant status
26.8
6.2
8
*
PC1BD
NOMESCO Finland
Extensive CT of thoracic aorta
26.8
6.2
8
*
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.7
6.2
129
798
ZXA00
NOMESCO Finland
Right side
1.5
6.2
273
2017
M01CB01
ATC
sodium aurothiomalate; parenteral
3.9
6.2
23
59
SPAT1249
SPAT
Treatment-related counselling outside office
1.4
6.2
379
2979
Z95.5
ICD-10 Finland
Presence of coronary angioplasty implant and graft
2.8
6.2
36
129
I95.9
ICD-10 Finland
Hypotension, unspecified
5.8
6.1
16
28
R5140
NOMESCO Finland
Monitoring the use of the aid
1.8
6.1
106
618
A03
ICPC
Fever
1.6
6.1
145
928
WX722
NOMESCO Finland
PEEP
2.4
6.1
48
205
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.6
6.1
160
1050
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
4.1
6.1
22
55
NHQ40
NOMESCO Finland
Amputation of toe
3.9
6.1
23
60
WW500
NOMESCO Finland
Blood transfusion
2.5
6.0
44
181
K30
ICD-10 Finland
Functional dyspepsia
1.8
6.0
96
545
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
702
2147
5.54
223.00
4.8
1.9
ng/l
2073.7
634.3
3.39
647
1723
(3023368) Bacteria identified in Blood by Culture
653
2621
3.79
129.71
7.5
4.0
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
213
376
6.50
118.64
1.6
1.5
u/ml
6.1
27.0
—
6
11
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
170
236
8.06
118.31
3.0
1.4
g/l
0.2
0.2
0.81
160
223
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
172
246
7.83
116.60
3.0
1.4
g/l
1.2
1.2
0.28
160
229
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
470
1646
3.79
111.95
7.4
2.9
ng/l
482.8
516.1
0.07
396
1250
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
348
1036
4.14
103.91
3.7
3.9
u/l
242.9
241.5
0.05
336
976
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
427
1475
3.72
102.74
2.4
1.7
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
753
3703
3.23
101.43
16.1
4.5
inr
1.4
1.1
9.66
208
1014
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
265
659
4.72
99.96
3.1
1.9
ug/l
9.3
5.7
1.46
222
562
(3022948) Iron [Moles/volume] in Serum or Plasma
394
1317
3.77
99.20
3.9
2.2
umol/l
11.3
14.0
10.69
383
1219
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
360
1135
3.92
98.70
4.1
2.2
%
20.8
24.7
5.68
331
968
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
174
305
6.37
97.02
1.7
1.6
titre
435.6
323.5
—
8
17
(3037522) Nuclear Ab [Titer] in Serum
368
1193
3.82
96.70
1.7
1.3
titre
562.6
435.7
0.62
107
242
(3004789) Transferrin [Mass/volume] in Serum or Plasma
372
1225
3.77
95.40
4.0
2.1
g/l
2.1
2.3
6.60
354
1136
(3020779) Urea [Moles/volume] in Serum or Plasma
273
731
4.39
93.34
13.0
6.1
mmol/l
10.6
8.8
3.38
259
691
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
237
572
4.78
92.42
3.8
1.9
ng/l
217.1
87.3
4.92
216
499
(3012441) Differential panel - Pleural fluid
82
57
15.22
91.86
1.5
1.3
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
385
1334
3.60
90.99
2.7
2.0
s
30.6
28.9
5.83
376
1297
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
133
190
7.63
89.78
1.9
1.9
mg/l
11.9
10.8
0.57
123
178
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
135
197
7.47
89.42
1.8
1.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
322
1005
3.86
88.79
2.2
1.6
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
878
4975
3.04
87.60
11.4
5.7
e9/l
0.0
0.0
0.16
773
4253
(3042936) Bacteria identified in Isolate by Culture
382
1348
3.52
87.38
2.6
2.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
113
138
8.82
86.98
1.8
1.7
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
873
4951
3.02
86.59
11.5
5.7
e9/l
0.7
0.6
10.61
770
4225
(40768806) Pleura Pathology biopsy report
84
68
13.07
86.16
1.5
1.5
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
889
5112
3.01
85.58
11.5
5.8
e9/l
1.7
2.0
3.36
796
4447
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
317
1011
3.76
84.35
2.3
1.6
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
888
5141
2.98
83.70
11.9
6.0
e9/l
0.2
0.2
0.55
794
4471
(42870588) Differential panel, method unspecified - Blood
673
3378
2.90
82.74
11.2
5.7
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
82
69
12.56
82.10
1.4
1.2
e6/l
2081.9
1938.0
0.11
58
49
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
125
186
7.28
81.22
1.8
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
126
191
7.15
80.48
1.9
1.7
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
829
4695
2.87
80.20
12.5
6.3
%
9.2
8.8
3.62
799
4365
(3028308) Erythrocytes [#/volume] in Pleural fluid
78
63
13.05
80.06
1.4
1.3
e6/l
36251.9
71508.4
0.39
44
37
(3006504) Eosinophils/100 leukocytes in Blood
826
4672
2.86
80.06
12.1
6.0
%
2.7
2.9
2.06
793
4324
(3022096) Basophils/100 leukocytes in Blood
811
4546
2.85
79.94
12.2
6.1
%
0.6
0.7
2.91
780
4204
(3012095) Magnesium [Moles/volume] in Serum or Plasma
381
1413
3.33
79.70
5.5
3.2
mmol/l
0.8
0.8
0.57
355
1321
(3002030) Lymphocytes/100 leukocytes in Blood
839
4823
2.84
78.15
12.2
6.1
%
23.9
28.1
23.66
802
4471
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
879
5180
2.86
77.96
8.5
6.3
umol/l
11.7
11.7
0.00
854
4922
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
687
3589
2.79
76.69
6.2
2.7
ng/l
112.5
54.0
0.40
526
2421
(3018010) Neutrophils/100 leukocytes in Blood
821
4751
2.75
74.05
11.9
5.9
%
60.9
56.9
17.31
789
4432
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
153
307
5.47
73.48
2.7
2.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
122
200
6.58
72.24
4.3
3.0
u/ml
0.3
0.3
0.22
73
104
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
100
136
7.84
70.22
3.7
3.4
u/ml
357.0
2250.5
—
7
12
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
84
92
9.65
70.15
1.7
1.8
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
929
5839
2.74
69.11
15.2
9.2
e9/l
4.6
4.1
7.01
822
5054
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
91
113
8.54
68.92
1.8
1.6
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
64
51
13.10
66.11
1.4
1.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
47
20
24.28
65.65
2.2
2.0
nmol/l
0.8
0.8
—
33
10
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
165
390
4.66
65.20
1.8
1.7
g/l
1.7
1.5
1.52
144
343
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
110
180
6.55
65.15
7.5
5.1
iu/ml
696.4
709.3
0.01
14
25
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
284
989
3.35
64.64
8.9
7.2
kpa
5.1
5.1
0.69
271
943
(3003396) Base excess in Arterial blood by calculation
283
989
3.33
64.00
9.0
7.2
mmol/l
1.2
1.0
0.56
228
753
(3027801) Oxygen [Partial pressure] in Arterial blood
283
990
3.33
63.89
8.9
7.2
kpa
11.3
12.6
4.92
269
945
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
443
2015
2.75
62.31
2.2
1.6
mg/l
1.3
1.3
0.10
365
1561
(3022217) INR in Platelet poor plasma by Coagulation assay
262
887
3.40
62.25
34.1
9.8
inr
1.7
1.1
2.78
27
151
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
817
4980
2.53
62.11
12.4
5.9
mmol/l
1.2
1.2
5.92
702
4183
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
158
376
4.61
61.82
2.4
1.8
ug/l
0.7
2.1
1.05
142
332
(3003458) Phosphate [Moles/volume] in Serum or Plasma
314
1190
3.11
61.80
11.6
5.1
mmol/l
1.1
1.0
6.60
294
1101
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
102
163
6.67
61.77
1.4
1.2
u/ml
291.9
234.0
1.12
79
97
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
155
367
4.62
61.01
2.0
1.7
u/l
34.8
40.4
2.27
140
333
(3020630) Protein [Mass/volume] in Serum or Plasma
237
764
3.53
60.74
2.3
2.7
g/l
64.5
67.3
5.94
224
695
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
559
2886
2.56
60.38
2.7
2.0
u/l
186.6
224.3
0.47
536
2697
(3013826) Glucose [Moles/volume] in Serum or Plasma
918
5961
2.56
60.06
8.9
4.0
mmol/l
6.8
6.7
0.72
888
5549
(3035947) Staphylolysin Ab [Units/volume] in Serum
53
37
14.85
58.99
1.1
1.1
iu/ml
4.0
—
—
6
0
(3016502) Oxygen saturation in Arterial blood
257
890
3.31
58.65
9.4
7.7
%
95.0
96.0
1.07
251
855
(3014111) Lactate [Moles/volume] in Serum or Plasma
235
771
3.46
58.47
9.9
6.3
mmol/l
1.3
1.4
0.61
223
743
(3015171) Extractable nuclear Ab [Units/volume] in Serum
139
312
4.83
58.36
1.4
1.2
u/ml
3.5
0.6
—
9
30
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
102
178
6.10
56.57
1.3
1.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
746
4501
2.40
55.96
11.8
5.3
mmol/l
1.2
1.2
7.44
719
4025
(3005719) IgG [Mass/volume] in Serum or Plasma
220
722
3.43
54.52
4.1
2.6
g/l
10.0
10.7
1.27
205
663
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
643
3679
2.38
53.87
5.0
3.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
221
739
3.36
53.09
13.9
7.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
126
283
4.79
52.76
3.1
1.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
87
139
6.61
52.61
1.8
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
625
3575
2.35
51.88
6.1
3.5
e6/l
55.8
106.9
1.14
486
2553
(3002582) Erythrocytes [#/volume] in Urine
564
3087
2.38
51.82
5.1
3.1
e6/l
126.4
82.1
0.22
453
2370
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
117
252
4.97
51.48
1.9
1.7
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
178
529
3.71
51.21
11.7
6.4
mmol/l
24.9
24.7
0.26
178
524
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
94
169
5.89
50.50
1.8
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
179
543
3.63
49.90
1.6
1.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
526
2836
2.37
49.56
5.1
3.0
e6/l
0.5
0.4
0.32
416
2133
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
90
158
6.02
49.54
1.8
1.4
u/ml
123.2
115.9
0.24
12
25
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
562
3124
2.33
49.26
3.4
2.5
u/l
55.5
56.5
0.12
528
2870
(3024561) Albumin [Mass/volume] in Serum or Plasma
706
4341
2.26
48.31
7.6
4.5
g/l
33.8
35.8
14.39
667
4021
(36304419) Bacteria [Presence] in Urine
513
2764
2.35
48.12
4.9
2.9
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
127
310
4.40
47.85
1.7
1.6
iu/ml
0.0
0.1
0.68
31
48
(3021447) Carbon dioxide [Partial pressure] in Venous blood
228
827
3.10
47.55
7.6
3.1
kpa
5.9
5.8
1.60
219
804
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
158
457
3.77
47.18
11.1
9.0
mmol/l
24.4
24.3
0.16
149
431
(3002032) Base excess in Venous blood by calculation
227
827
3.08
46.95
7.6
3.1
mmol/l
2.0
1.7
0.57
191
645
(3027945) Reticulocytes/100 erythrocytes in Blood
261
1034
2.87
46.40
3.4
2.4
%
1.8
1.7
1.28
240
912
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
451
2330
2.38
46.28
2.7
2.0
mg/l
3.1
2.8
1.99
390
1944
(3001122) Ferritin [Mass/volume] in Serum or Plasma
650
3914
2.23
46.22
4.3
2.5
ug/l
191.8
151.3
3.00
613
3577
(3018418) pH of Serum or Plasma
527
2919
2.29
45.87
7.9
3.6
ph
7.4
7.4
0.05
124
540
(3002173) Hemoglobin [Mass/volume] in Arterial blood
225
826
3.05
45.86
9.9
8.1
g/l
121.7
123.6
0.57
220
791
(3024980) IgG subclass 4 [Mass/volume] in Serum
79
132
6.28
45.68
1.3
1.8
g/l
0.6
0.9
0.94
67
103
(3028026) IgM [Mass/volume] in Serum or Plasma
179
575
3.42
45.55
2.6
1.8
g/l
1.2
1.5
1.42
171
527
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
145
408
3.85
45.00
8.7
3.8
mmol/l
24.3
24.0
0.61
133
375
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
102
222
4.88
44.24
1.5
1.2
u/ml
3.2
2.4
0.51
18
20
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
105
235
4.75
44.04
1.5
1.2
u/ml
27.8
21.9
—
8
14
(3048929) Epstein Barr virus Ab [Presence] in Serum
115
277
4.43
44.02
1.4
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
189
641
3.25
44.00
2.2
2.4
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
102
225
4.81
43.53
1.5
1.2
u/ml
10.8
13.6
0.16
23
32
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
71
112
6.62
43.40
1.7
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
90
179
5.30
43.30
1.8
1.8
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
273
1147
2.71
43.15
10.5
6.1
mmol/l
104.1
104.3
0.23
265
1123
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1069
8006
2.40
42.83
13.6
7.2
u/l
81.5
79.0
1.01
1028
7483
(3000850) Epithelial cells [#/volume] in Urine
415
2130
2.35
42.69
4.2
2.4
e6/l
6.5
4.7
0.46
386
1883
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
55
66
8.63
42.65
1.3
1.0
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
55
66
8.63
42.65
1.3
1.0
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
55
66
8.63
42.65
1.3
1.0
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
56
69
8.41
42.52
1.2
1.1
titre
390.0
178.0
0.61
12
15
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
54
64
8.73
42.29
1.3
1.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
54
64
8.73
42.29
1.3
1.0
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
54
64
8.73
42.29
1.3
1.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
327
1516
2.51
42.14
2.0
1.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
187
652
3.15
41.47
1.8
1.6
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
468
2556
2.25
41.30
6.7
3.6
%
83.1
93.2
14.47
462
2506
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
66
104
6.61
40.37
1.7
1.4
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
925
6608
2.17
40.32
6.0
4.1
e6/l
1891.9
1858.2
0.01
16
103
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
110
277
4.22
39.69
2.6
3.6
mg/l
39.2
70.2
0.77
88
230
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
59
85
7.20
39.20
1.3
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
70
121
6.04
39.08
1.7
1.4
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
109
277
4.18
38.84
2.6
3.6
mg/l
51.7
42.1
1.24
89
230
(3026782) Osmolality of Urine
388
2008
2.29
38.58
4.3
2.6
mosm/kgh2o
532.4
578.1
4.01
350
1720
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
112
292
4.08
38.56
2.2
2.0
ug/l
188.4
447.9
2.18
101
271
(3021589) Normoblasts [#/volume] in Blood
696
4520
2.07
38.46
19.0
8.6
e9/l
0.0
0.0
0.35
564
3681
(40758558) Short blood count panel - Blood
447
2458
2.20
38.28
11.8
6.9
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
190
700
2.98
38.16
5.8
2.6
kpa
4.8
4.6
0.47
179
683
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
52
67
8.02
38.04
1.7
1.6
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
78
154
5.30
37.80
5.7
2.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
961
7055
2.15
37.80
6.7
4.0
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
80
162
5.18
37.68
1.4
1.2
u/ml
47.9
26.9
0.46
14
18
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
84
179
4.93
37.30
1.4
1.2
u/ml
23.2
1.7
—
8
12
(3017143) Hepatitis C virus Ab [Presence] in Serum
248
1063
2.62
37.27
2.0
1.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
534
3173
2.10
37.21
4.0
3.3
u/l
36.6
33.3
0.56
505
3014
(3015736) pH of Urine
615
3855
2.06
37.04
4.5
3.2
—
5.9
—
0
7
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
344
1724
2.32
36.68
3.8
2.7
e6/l
0.9
1.1
0.77
200
961
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
105
271
4.11
36.62
2.6
3.6
ratio
1.5
1.8
—
9
22
(3042733) HLA Ab [Presence] in Serum
33
23
14.67
36.58
5.3
5.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
115
318
3.85
36.45
1.9
2.3
g/l
3.6
3.1
4.85
93
252
(3023520) Reticulocytes [#/volume] in Blood
196
760
2.83
35.75
2.8
2.4
e9/l
75.6
67.6
2.03
128
572
(3019060) Gas panel - Arterial blood
160
556
3.12
35.50
4.7
5.1
—
—
—
0
0
(44790048)
57
90
6.56
34.77
1.9
1.6
—
—
—
0
0
(44806118)
57
90
6.56
34.77
1.9
1.6
—
—
—
0
0
(44790049)
57
90
6.56
34.77
1.9
1.6
—
—
—
0
0
(44790047)
57
90
6.56
34.77
1.9
1.6
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
96
241
4.20
34.73
1.6
2.2
g/l
0.0
0.0
0.00
84
226
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
80
175
4.79
34.42
1.5
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
80
175
4.79
34.42
1.5
1.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
114
326
3.72
34.40
1.9
2.3
g/l
11.2
10.5
0.68
96
277
(3035880) pH of Pleural fluid
35
30
11.94
34.38
1.4
1.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
118
346
3.63
34.31
1.9
2.2
g/l
8.2
7.3
3.84
95
256
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
118
346
3.63
34.31
1.9
2.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
118
346
3.63
34.31
1.9
2.2
g/l
4.3
3.9
1.04
92
247
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
96
245
4.13
33.97
1.7
2.2
g/l
0.0
0.0
0.00
84
227
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
318
1587
2.30
33.96
1.4
1.3
iu/ml
52.1
33.1
1.37
106
503
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
99
259
4.04
33.87
1.8
2.2
g/l
0.1
0.0
0.33
87
240
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
322
1623
2.28
33.54
4.0
2.9
e6/l
2.3
1.9
0.35
179
866
(3021879) Hepatitis B virus core Ab [Presence] in Serum
179
685
2.85
33.37
1.5
1.4
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
51
75
7.02
33.24
1.2
1.2
g/l
0.4
0.4
0.16
40
50
(3028192) IgG subclass 2 [Mass/volume] in Serum
51
75
7.02
33.24
1.2
1.2
g/l
2.7
2.9
0.26
40
51
(3027135) IgG subclass 1 [Mass/volume] in Serum
51
75
7.02
33.24
1.2
1.2
g/l
6.7
7.0
0.12
39
51
(4062490)
50
74
6.97
32.39
1.3
1.2
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
100
275
3.84
31.90
1.7
2.1
g/l
34.5
38.3
6.72
87
237
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
105
300
3.70
31.69
2.2
2.3
g/l
1.1
1.6
0.44
92
259
(3013707) Erythrocyte sedimentation rate by Westergren method
997
7662
2.04
31.41
7.8
3.7
mm/h
17.4
11.3
19.03
944
7035
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
261
1236
2.37
31.25
1.9
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
101
285
3.74
31.04
1.6
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
516
3187
1.98
31.02
3.5
2.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
152
556
2.94
30.70
1.9
1.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
717
4977
1.90
30.06
7.3
4.6
estimate
0.0
0.0
0.50
150
942
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
211
925
2.51
29.86
2.5
2.3
g/l
0.2
0.2
0.21
197
878
(3027315) Oxygen [Partial pressure] in Blood
77
184
4.37
29.68
7.2
3.4
kpa
8.6
8.6
0.03
77
179
(3012501) Base excess in Blood by calculation
77
185
4.35
29.47
7.2
3.4
mmol/l
2.8
2.1
1.14
62
121
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
40
52
7.89
29.01
1.6
1.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
78
192
4.24
28.93
1.4
1.5
—
—
—
0
0
(3010421) pH of Blood
87
233
3.91
28.79
7.0
3.1
ph
7.4
7.4
0.47
77
181
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
35
39
9.18
28.67
3.0
2.1
u/ml
728.7
1528.6
0.72
35
39
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
134
475
3.01
28.57
14.0
9.9
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
92
258
3.75
28.51
3.5
2.2
%
91.7
92.0
0.04
92
241
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
687
4761
1.87
28.39
5.1
3.9
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
716
5029
1.86
28.33
5.4
3.4
estimate
0.0
0.0
0.80
146
896
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
205
911
2.46
28.09
3.9
2.5
u/l
32.3
95.6
0.64
173
781
(3035350) Ketones [Presence] in Urine by Test strip
708
4967
1.86
28.00
5.4
3.3
estimate
0.0
0.0
0.00
148
921
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
87
238
3.83
27.94
8.5
3.9
mg/l
1.8
1.4
3.07
81
220
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
413
2436
1.98
27.79
3.3
2.3
—
—
—
0
0
(3024932) HLA-DR beta [Type]
29
26
11.37
27.62
1.1
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
243
1173
2.30
27.59
1.8
1.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
454
2779
1.94
27.32
3.4
3.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
74
183
4.21
27.28
6.5
2.9
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
189
824
2.49
26.94
3.2
2.3
nmol/l
340.8
366.9
1.27
176
762
(3007853) Bacteria identified in Skin by Aerobe culture
229
1090
2.32
26.82
2.3
1.6
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
292
1536
2.14
26.74
1.4
1.2
u/ml
28.9
11.5
1.83
94
578
(3024471) HLA-A [Type]
28
25
11.41
26.73
1.0
1.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
44
70
6.46
26.63
1.7
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
44
70
6.46
26.63
1.7
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
44
70
6.46
26.63
1.7
1.4
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
46
77
6.14
26.50
2.3
2.8
e9/l
1.0
1.1
0.24
28
42
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
24
17
14.35
26.25
1.3
1.4
ug/l
164.9
283.4
—
9
11
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
81
221
3.83
26.10
1.3
1.7
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
430
2620
1.92
26.00
4.2
2.4
umol/l
4531.2
5926.2
0.26
385
2284
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
148
586
2.71
25.65
6.5
2.9
mmol/l
1.9
1.5
0.40
108
421
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
64
149
4.45
25.49
2.0
1.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
162
675
2.58
25.34
7.3
3.6
ng/l
127.4
79.9
4.12
149
592
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
40
61
6.72
25.19
1.2
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
49
92
5.48
25.07
1.8
1.5
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
76
204
3.88
25.06
3.0
3.9
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
384
2277
1.94
25.04
4.8
3.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
88
262
3.52
24.94
1.4
1.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
226
1102
2.25
24.88
4.5
2.8
umol/l
6.4
9.1
2.21
208
979
(3007164) IgA [Mass/volume] in Serum or Plasma
328
1846
2.01
24.84
2.1
1.5
g/l
2.7
2.5
0.51
234
1115
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
87
258
3.53
24.80
1.2
1.1
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
151
615
2.63
24.72
6.6
2.9
kpa
5.1
5.1
0.04
145
565
(3009343) pH of Capillary blood
150
609
2.64
24.71
6.6
2.9
ph
7.4
7.4
0.17
28
68
(3044889) 12 lead EKG panel
934
7298
1.83
24.53
6.4
3.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
68
172
4.10
24.32
3.8
2.4
%
15.4
16.7
1.36
32
90
(40768446) Kidney Pathology biopsy report
28
30
9.50
23.58
2.0
1.7
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
34
47
7.39
23.38
1.7
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
34
47
7.39
23.38
1.7
1.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
45
84
5.50
23.17
1.9
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
816
6191
1.76
22.96
3.2
2.8
—
—
—
0
0
(3013512) EKG study
452
2893
1.83
22.89
5.8
3.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
57
135
4.36
22.22
1.5
1.2
u/ml
7.6
2.5
0.80
27
44
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
41
73
5.76
22.18
1.9
1.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
85
272
3.26
21.50
1.4
1.2
—
—
—
0
0
(4268621)
45
90
5.13
21.48
2.7
2.2
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
132
542
2.58
21.19
7.9
7.0
mmol/l
25.1
24.4
1.11
127
499
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
576
4043
1.72
20.72
3.0
2.2
nmol/l
77.8
77.5
0.08
534
3572
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
54
130
4.28
20.62
1.5
1.2
u/ml
5.6
3.3
0.64
34
55
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
66
187
3.65
20.15
1.2
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
354
2173
1.84
20.12
7.6
4.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
55
137
4.14
20.09
1.1
1.1
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
80
260
3.20
19.73
1.3
1.2
titre
132.0
83.7
—
5
27
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
32
52
6.27
18.97
2.5
3.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
54
139
4.00
18.88
2.2
2.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1208
10557
2.03
18.86
33.8
11.9
mg/l
28.8
25.8
2.59
1104
8108
(3047007) Chlamydophila sp Ab [Presence] in Serum
53
139
3.92
18.07
1.2
1.2
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
78
265
3.06
17.86
1.2
1.2
—
1168.3
—
0
6
(3015235) Bicarbonate [Moles/volume] in Capillary blood
69
220
3.25
17.56
4.8
2.4
mmol/l
24.7
24.7
0.02
61
191
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
29
47
6.28
17.24
1.1
2.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
29
47
6.28
17.24
1.1
2.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
167
831
2.15
17.20
6.8
4.3
%
1.1
0.8
0.71
56
242
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
32
58
5.62
17.00
2.2
2.9
%
15.6
14.9
0.04
14
23
(3025941) Bacteria identified in Stool by Culture
120
525
2.41
16.78
1.4
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
306
1888
1.79
16.73
2.0
1.7
nmol/l
1116.0
1155.6
0.31
240
1406
(3052851) Hemolysis interference index of Serum or Plasma
76
265
2.97
16.63
4.5
3.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
36
75
4.90
16.42
1.5
1.0
u/ml
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
27
43
6.38
16.32
1.8
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
27
43
6.38
16.32
1.8
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
27
43
6.38
16.32
1.8
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
27
43
6.38
16.32
1.8
1.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
87
331
2.74
16.22
4.2
3.4
g/l
0.6
0.2
2.00
52
148
(3025159) Blasts/100 leukocytes in Blood
151
742
2.16
16.03
6.7
4.5
%
0.0
0.1
1.66
44
186
(3043409) Potassium [Moles/volume] in Arterial blood
73
255
2.96
15.93
3.9
3.6
mmol/l
3.9
3.9
0.13
66
238
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
39
90
4.43
15.74
2.3
2.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
472
3322
1.63
15.73
4.4
3.2
mmol/l
7.8
8.1
0.68
402
2785
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
913
7514
1.61
15.72
4.4
3.5
pmol/l
15.1
14.8
2.89
847
6707
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
190
1027
1.98
15.59
5.3
2.9
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
39
91
4.38
15.53
3.4
4.3
—
—
—
0
0
(3004451) EKG impression Narrative
26
42
6.29
15.50
1.3
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
38
87
4.46
15.49
1.2
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
200
1103
1.95
15.48
2.8
4.5
ug/l
6.5
24.3
1.41
156
911
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
846
6855
1.59
15.39
4.1
3.0
u/l
68.1
50.9
2.76
798
6346
(3002179) Metamyelocytes/100 leukocytes in Blood
150
747
2.13
15.37
6.4
4.2
%
0.9
0.5
0.62
42
176
(3020682) Albumin/Creatinine [Ratio] in Urine
467
3293
1.63
15.37
5.3
3.9
mg/mmol
19.1
5.9
2.62
317
2102
(3015377) Calcium [Moles/volume] in Serum or Plasma
483
3436
1.62
15.33
4.6
3.3
mmol/l
2.3
2.4
0.90
418
2986
(3021440) Promyelocytes/100 leukocytes in Blood
155
784
2.10
15.25
6.9
4.4
%
0.1
0.1
0.71
49
222
(3012516) Albumin [Mass/volume] in Urine
446
3122
1.63
15.06
4.3
3.2
mg/l
538.0
265.9
0.61
317
1982
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
14
10
14.13
15.06
1.1
1.0
%
83.4
104.3
—
14
10
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
14
10
14.13
15.06
1.1
1.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
106
462
2.40
14.94
6.8
3.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
70
248
2.92
14.91
1.3
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
25
41
6.19
14.69
1.2
1.1
iu/ml
218.9
231.0
0.05
25
41
(3034426) Prothrombin time (PT)
18
20
9.10
14.68
1.6
1.3
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
22
32
6.97
14.44
2.7
1.2
ug/l
27.5
319.8
0.46
22
23
(3037692) Legionella sp identified in Specimen by Organism specific culture
22
32
6.97
14.44
2.0
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
150
766
2.07
14.37
3.9
2.6
ml/min/173m2
59.2
69.2
1.94
74
304
(3023419) Bacteria identified in Sputum by Culture
42
111
3.87
14.20
2.4
2.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
51
154
3.40
14.18
4.1
2.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
358
2406
1.65
14.06
1.8
1.5
nmol/l
19.4
20.5
0.85
319
2021
(3048689) Calprotectin [Mass/mass] in Stool
199
1130
1.89
14.05
2.4
2.4
ug/g
189.4
142.0
0.56
165
898
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
131
643
2.14
13.92
1.5
1.3
au/ml
38.3
63.4
0.94
11
31
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
15
14
10.82
13.77
5.9
5.9
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
567
4268
1.55
13.74
2.3
1.9
pmol/l
96.5
94.2
0.52
327
2262
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
155
815
2.01
13.70
7.5
3.5
mmol/l
1.2
1.2
0.93
149
705
(3002621) Streptococcal DNAse B [Units/volume] in Serum
17
5
34.38
13.51
1.1
1.0
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
139
707
2.07
13.45
2.6
2.5
au/ml
42.7
21.7
—
7
38
(3003327) Ova and parasites identified in Stool by Light microscopy
73
282
2.68
13.24
1.7
1.6
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
20
29
6.98
13.16
3.1
2.7
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
19
26
7.39
13.14
1.4
1.2
—
—
—
0
0
(3020891) Body temperature
83
343
2.51
13.13
6.3
3.8
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1074
9357
1.63
13.13
5.3
4.2
mu/l
3.0
2.2
0.35
1004
8420
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
30
65
4.69
13.09
1.8
2.6
e6/l
458.1
894.9
2.64
14
27
(3035637) Corticotropin [Mass/volume] in Plasma
41
114
3.67
12.92
1.5
1.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
43
126
3.49
12.54
1.1
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
64
238
2.77
12.50
1.9
1.7
e6/l
13241.9
15643.0
0.14
49
164
(3005322) IgE [Units/volume] in Serum or Plasma
112
541
2.16
12.39
1.6
1.2
u/ml
521.9
269.5
0.63
107
501
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
50
164
3.12
12.20
1.3
1.2
—
—
—
0
0
(4035726)
161
897
1.90
11.99
1.6
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
89
399
2.31
11.79
2.3
1.8
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
35
93
3.83
11.78
1.5
1.2
u/l
58.6
66.1
0.37
28
67
(3021788) Differential panel - Synovial fluid
52
179
2.98
11.70
2.0
1.6
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
31
76
4.15
11.62
1.7
2.2
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
15
18
8.41
11.50
2.1
4.6
e6/l
162.0
158.0
—
10
5
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
66
262
2.59
11.37
1.7
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
54
193
2.87
11.37
5.6
3.7
%
60.6
56.6
1.39
54
193
(3006184) Hemoglobin [Mass/volume] in Capillary blood
53
191
2.84
11.00
3.6
2.1
g/l
123.6
133.1
1.58
39
132
(40768804) Tissue Pathology biopsy report
536
4131
1.48
10.92
2.5
2.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
23
47
4.96
10.75
1.2
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
52
188
2.83
10.73
4.8
3.5
e9/l
4.5
4.1
0.48
52
188
(3011648) Oxygen content in Venous blood
29
72
4.09
10.71
3.3
1.8
%
11.6
10.7
0.48
29
72
(3019550) Sodium [Moles/volume] in Serum or Plasma
1213
11062
1.71
10.64
35.6
13.4
mmol/l
139.3
139.7
6.56
1190
10720
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
280
1889
1.60
10.48
3.6
3.0
mmol/l
2.5
2.4
1.32
244
1681
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1120
10039
1.57
10.27
28.0
11.3
ml/min/173m2
78.5
81.6
3.81
987
8100
(3023103) Potassium [Moles/volume] in Serum or Plasma
1214
11100
1.69
10.21
36.2
13.5
mmol/l
4.0
4.0
1.93
1190
10736
(3002385) Erythrocyte distribution width [Ratio]
999
8761
1.49
9.96
36.8
14.9
%
14.0
13.6
15.31
985
8548
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
16
25
6.46
9.82
2.8
1.8
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
16
25
6.46
9.82
1.1
1.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
46
164
2.87
9.76
1.7
1.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
84
399
2.18
9.71
1.1
1.2
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
11
11
10.07
9.55
8.2
5.8
mmol/l
6.2
5.1
0.51
11
11
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
37
118
3.19
9.51
1.1
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
500
3881
1.45
9.48
5.8
3.5
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
16
26
6.21
9.47
1.1
1.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
80
378
2.18
9.38
2.1
1.6
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
31
89
3.54
9.37
1.2
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
36
114
3.21
9.36
1.3
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
34
104
3.33
9.34
1.1
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
40
137
2.98
9.13
1.6
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
28
77
3.69
9.02
1.3
2.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
30
87
3.50
8.95
1.2
1.2
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
18
35
5.20
8.89
1.6
3.2
—
859.8
—
0
6
(3045142) Bone marrow Pathology biopsy report
34
108
3.20
8.81
1.5
1.3
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
11
13
8.52
8.47
1.0
1.2
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
12
16
7.56
8.42
1.3
1.4
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
17
33
5.20
8.41
2.6
1.8
%
3.9
9.4
1.51
17
33
(21494814) CD8 cells/100 lymphocytes in Specimen
17
33
5.20
8.41
2.6
1.8
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
43
161
2.72
8.37
1.3
1.4
mmol/l
65.0
67.3
0.12
35
127
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
290
2077
1.50
8.11
1.3
1.3
u/ml
1.1
1.6
0.84
78
533
(3044927) Protein electrophoresis panel - Urine
31
98
3.21
8.11
1.1
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
41
153
2.73
8.04
1.7
1.6
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
11
14
7.91
7.99
9.6
6.7
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
16
31
5.21
7.94
28.8
4.4
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
17
35
4.90
7.89
2.1
1.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
17
35
4.90
7.89
2.1
1.6
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
17
35
4.90
7.89
2.1
1.6
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
68
324
2.15
7.85
1.8
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
141
858
1.72
7.80
6.7
3.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
209
1406
1.57
7.77
1.3
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
227
1557
1.55
7.75
1.6
1.4
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
15
28
5.40
7.73
2.3
2.3
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
47
194
2.47
7.55
2.1
3.2
umol/l
30.9
35.6
1.12
41
164
(3009542) Hematocrit [Volume Fraction] of Blood
1072
9720
1.43
7.45
31.0
13.1
%
39.1
40.2
3.21
742
6944
(3051611) Lipemic interference index of Serum or Plasma
29
93
3.16
7.43
5.7
3.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
34
120
2.88
7.40
1.5
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
173
1127
1.61
7.36
1.4
1.3
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
33
115
2.91
7.35
2.1
1.6
%
55.0
59.7
0.30
25
81
(3000570) Elastase.pancreatic [Mass/mass] in Stool
59
274
2.20
7.27
1.4
1.4
ug/g
232.3
266.7
0.60
39
164
(3029937) Albumin [Presence] in Urine by Test strip
357
2713
1.42
7.25
6.3
3.5
estimate
0.0
0.0
1.08
139
912
(3047181) Lactate [Moles/volume] in Blood
59
275
2.20
7.21
8.0
7.2
mmol/l
1.3
1.3
0.20
49
236
(3019977) pH of Arterial blood
19
47
4.08
7.09
2.5
3.3
ph
7.4
7.4
—
7
16
(40768795) Lymph node Pathology biopsy report
28
93
3.05
6.79
1.2
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
89
493
1.86
6.77
2.4
2.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
25
78
3.25
6.71
1.2
1.1
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
75
394
1.95
6.69
3.3
3.4
u/ml
176.7
3465.8
0.69
62
332
(40761511) CBC panel - Blood by Automated count
1192
11092
1.49
6.66
26.2
11.3
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
40
164
2.48
6.56
4.2
3.6
%
2.3
1.3
0.53
28
128
(3001964) Herpes simplex virus Ag [Presence] in Specimen
13
25
5.24
6.49
2.5
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
354
2741
1.39
6.34
5.3
3.1
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
81
445
1.87
6.34
3.0
3.3
pmol/l
4.3
4.7
1.94
68
391
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
18
47
3.87
6.27
1.2
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1074
9837
1.39
6.27
7.5
5.6
mmol/mol
41.2
39.7
4.84
996
9050
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
9
5
18.10
6.27
1.1
1.0
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
1220
11443
1.50
6.17
35.3
14.0
umol/l
89.5
78.3
8.97
1220
11436
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1220
11445
1.50
6.14
19.0
9.6
u/l
28.7
27.4
1.53
1186
10966
(3051651) Icteric interference index of Serum or Plasma
19
53
3.62
6.05
6.9
3.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
15
35
4.32
6.03
1.1
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
38
159
2.43
5.99
1.1
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
13
27
4.85
5.98
1.2
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
360
2828
1.37
5.84
1.5
1.4
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
25
86
2.94
5.74
2.2
1.5
%
35.5
29.8
0.28
15
54
(4010399)
115
722
1.65
5.69
1.6
1.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
58
296
2.00
5.66
1.5
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
85
493
1.77
5.61
4.3
3.6
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
21
66
3.21
5.60
2.2
2.0
—
2.2
—
0
5
(36660697) Celiac disease serology panel - Serum
117
742
1.63
5.57
1.2
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
58
298
1.99
5.56
1.5
1.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
16
42
3.84
5.54
1.8
3.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
25
88
2.87
5.53
1.2
1.2
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
25
89
2.84
5.42
1.3
1.4
e6/l
116110.3
92286.2
0.09
20
55
(42529406) Shigella sp [Presence] in Stool by Culture
58
301
1.97
5.41
1.5
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
104
649
1.65
5.28
1.6
1.6
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
15
39
3.88
5.27
1.3
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
194
1394
1.45
5.23
1.4
1.3
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
20
64
3.16
5.20
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
20
64
3.16
5.20
1.0
1.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
34
145
2.38
5.18
10.4
2.6
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
14
35
4.03
5.17
1.2
1.1
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
8
6
13.40
5.08
1.0
1.2
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
8
6
13.40
5.08
1.1
1.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
20
66
3.06
4.95
1.0
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
8
7
11.48
4.78
2.3
1.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1085
10093
1.33
4.71
4.8
3.8
mmol/l
1.4
1.3
1.29
1006
9133
(3017732) Neutrophils [#/volume] in Blood
106
687
1.59
4.64
3.7
3.6
e9/l
4.9
4.2
1.79
83
535
(40761535) Cells panel - Urine sediment
125
842
1.53
4.63
5.0
3.2
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
7
5
14.06
4.58
1.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
7
5
14.06
4.58
1.0
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
7
5
14.06
4.58
2.1
1.6
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
9
11
8.23
4.56
8.3
7.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
91
572
1.63
4.52
1.3
1.2
iu/ml
135.8
151.0
0.11
26
220
(3036603) Volume of Urine
18
59
3.08
4.52
1.4
1.4
ml
2210.3
1752.3
—
6
15
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
20
70
2.88
4.50
3.4
2.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
34
155
2.22
4.49
1.0
1.1
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
15
44
3.44
4.47
1.3
1.3
ratio
1.1
1.1
—
5
19
(3000492) Spirometry study
142
991
1.48
4.45
1.8
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
32
143
2.27
4.43
1.2
1.2
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
8
9
8.93
4.28
1.3
1.3
ng/l
91.1
81.1
—
8
9
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
15
46
3.29
4.19
3.1
1.8
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
44
228
1.96
4.19
2.8
3.9
u/ml
158.2
1547.0
0.69
39
216
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
9
13
6.96
4.16
1.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
9
13
6.96
4.16
1.0
1.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
26
109
2.41
4.16
1.7
1.3
nmol/l
—
—
—
0
0
(3022621) pH of Urine by Test strip
96
626
1.57
4.12
2.8
2.8
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
10
23
4.37
4.09
1.0
1.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
21
80
2.65
4.07
1.4
2.0
u/field
1.1
3.0
1.18
11
30
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
7
7
10.04
4.01
1.0
1.0
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
7
7
10.04
4.01
9.6
8.9
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
9
14
6.46
3.98
1.0
1.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
9
14
6.46
3.98
2.8
1.9
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
74
458
1.65
3.94
1.5
1.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
20
76
2.66
3.90
1.1
1.0
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
27
120
2.27
3.82
2.5
1.8
mmol/l
104.8
105.8
0.47
27
120
(3041354) Potassium [Moles/volume] in Venous blood
27
120
2.27
3.82
2.5
1.8
mmol/l
4.0
4.1
0.20
27
120
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
9
15
6.03
3.82
1.3
2.4
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
6
5
12.04
3.76
2.7
1.8
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
14
45
3.13
3.65
3.2
2.4
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
28
129
2.19
3.65
1.9
1.3
nmol/l
0.6
0.6
0.20
28
122
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
19
73
2.62
3.64
1.4
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
23
98
2.37
3.58
1.5
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1111
10489
1.28
3.53
5.2
4.2
mmol/l
1.3
1.4
8.99
1033
9564
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
10
26
3.87
3.52
1.1
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
26
118
2.23
3.52
2.5
1.8
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
8
13
6.18
3.50
1.0
1.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
26
120
2.19
3.39
2.0
1.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
19
76
2.52
3.38
2.7
2.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
9
18
5.02
3.37
2.3
1.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
11
32
3.46
3.33
1.2
1.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
973
9071
1.24
3.31
38.5
15.6
g/l
331.1
333.6
12.83
964
8985
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
20
84
2.40
3.23
1.3
1.2
nmol/l
1.7
1.3
0.64
20
73
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
37
199
1.88
3.22
1.6
1.8
iu/l
5.8
4.8
—
10
68
(3019225) pH of Specimen
142
1055
1.38
3.20
6.7
3.8
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
8
15
5.36
3.19
1.6
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
48
281
1.73
3.19
5.1
4.4
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
7
11
6.39
3.18
1.4
2.7
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
28
137
2.07
3.18
1.3
1.1
—
—
—
0
0
(1002224) Polysomnography panel
65
413
1.60
3.17
1.0
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
68
438
1.58
3.14
2.2
1.8
—
—
—
0
0
(3024263) Appearance of Synovial fluid
14
50
2.82
3.09
1.6
1.6
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
29
3.47
3.05
3.0
1.9
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
29
3.47
3.05
3.0
1.9
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
44
255
1.75
3.04
1.2
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
270
2218
1.27
3.01
5.5
3.7
kg/l
1.0
1.0
0.50
39
320
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1093
10357
1.25
3.01
5.4
4.4
mmol/l
6.1
6.0
3.15
1004
9335
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
5
5
10.03
2.98
1.8
3.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1112
10561
1.25
2.98
5.3
4.3
mmol/l
4.3
4.7
19.30
1042
9698
(3017704) Immunofixation for Urine
15
57
2.65
2.97
1.2
1.5
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
15
57
2.65
2.97
1.7
1.5
u/l
6.6
4.4
—
7
28
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
13
46
2.84
2.92
1.2
1.0
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
13
46
2.84
2.92
1.9
1.3
%
1.8
1.6
—
5
11
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
29
149
1.97
2.91
1.2
1.1
u/ml
6.4
2.8
0.30
16
62
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
274
2265
1.26
2.90
1.8
1.7
pmol/l
23077376.6
33651206.1
0.17
234
1890
(3036048) Francisella tularensis Ab [Titer] in Serum
9
22
4.11
2.88
1.1
1.2
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
16
64
2.52
2.87
1.6
1.2
u/ml
30.0
24.3
—
5
12
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
16
64
2.52
2.87
1.4
1.2
u/ml
0.3
0.7
—
10
32
(3008401) Mugwort IgE Ab [Units/volume] in Serum
26
129
2.03
2.87
1.2
1.1
u/ml
0.5
1.0
0.47
13
53
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
6
9
6.69
2.87
1.0
1.6
—
—
—
0
0
(3025315) Body weight
6
9
6.69
2.87
6.7
3.0
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
25
123
2.05
2.82
1.2
1.0
u/ml
1.7
3.4
—
10
28
(42529582) MDA5 Ab [Presence] in Serum by Line blot
10
31
3.24
2.77
1.3
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
10
31
3.24
2.77
1.3
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
10
31
3.24
2.77
1.3
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
10
31
3.24
2.77
1.3
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
26
131
2.00
2.76
1.2
1.0
u/ml
3.1
6.5
0.90
15
70
(3039744) RNA polymerase III Ab [Units/volume] in Serum
5
6
8.36
2.75
1.2
1.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
7
14
5.02
2.73
1.1
1.2
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
7
14
5.02
2.73
1.3
1.0
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
10
6.02
2.70
1.3
1.1
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
22
105
2.11
2.69
1.0
1.5
mosm/kgh2o
288.2
282.0
0.40
14
76
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
25
126
2.00
2.66
3.4
1.8
mg/l
20.2
21.1
—
9
30
(3017569) Oxygen content in Arterial blood
11
38
2.91
2.58
1.6
3.5
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
11
38
2.91
2.58
1.3
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
8
20
4.02
2.57
1.6
1.9
—
—
—
0
0
(3001729) Color of Synovial fluid
5
7
7.16
2.55
1.0
1.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
13
50
2.61
2.53
1.3
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
35
202
1.75
2.50
2.9
2.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
9
26
3.48
2.48
1.0
1.0
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
9
26
3.48
2.48
1.6
1.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
42
257
1.65
2.44
3.2
2.2
ug/min
129.2
99.8
0.22
32
159
(3002523) Influenza virus A Ag [Presence] in Specimen
29
160
1.83
2.40
1.1
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
11
40
2.76
2.37
1.5
1.4
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
8
22
3.65
2.36
1.0
1.0
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
35
206
1.72
2.35
3.7
2.4
mmol/l
7.8
7.6
0.15
35
200
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1126
10787
1.22
2.33
5.8
4.7
mmol/l
2.5
2.8
18.17
1048
9850
(3003740) Influenza virus B Ag [Presence] in Specimen
29
162
1.81
2.32
1.1
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
10
35
2.87
2.30
1.1
1.0
miu/ml
1425.6
1619.9
—
10
35
(3014271) Vancomycin [Susceptibility]
11
41
2.70
2.28
2.3
2.4
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
36
216
1.68
2.27
3.7
2.4
mmol/l
1.5
1.6
0.36
36
210
(3007461) Platelets [#/volume] in Blood
1238
11992
1.27
2.25
44.4
17.9
e9/l
251.4
247.4
1.11
1210
11599
(4094501)
42
264
1.61
2.22
1.0
1.1
—
—
—
0
0
(4306422)
24
128
1.89
2.22
1.4
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
19
93
2.06
2.22
1.5
1.2
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
5
9
5.57
2.21
2.6
1.6
umol/l
44.4
52.9
—
5
9
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
23
121
1.92
2.21
1.3
1.3
pmol/l
234.9
272.8
0.29
16
93
(3035941) MCH [Entitic mass]
1238
11997
1.27
2.21
44.1
17.8
pg
30.3
30.4
2.42
1220
11761
(3024731) MCV [Entitic volume]
1238
11997
1.27
2.21
44.1
17.9
fl
91.3
91.0
1.74
1220
11763
(3026361) Erythrocytes [#/volume] in Blood
1238
11998
1.27
2.20
44.3
17.9
e12/l
4.4
4.5
18.35
1209
11561
(3010813) Leukocytes [#/volume] in Blood
1238
12000
1.27
2.18
44.3
18.0
e9/l
7.3
6.7
12.41
1210
11567
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
8
24
3.35
2.18
1.0
1.2
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1238
12001
1.27
2.17
44.8
18.0
g/l
131.8
137.4
26.78
1222
11764
(21494755) Public health laboratory ask at order entry panel
70
971
0.71
2.15
1.4
1.4
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
7
19
3.70
2.15
1.1
1.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
17
81
2.11
2.13
1.0
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
5
10
5.01
2.07
1.4
1.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
5
10
5.01
2.07
1.8
1.6
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
6
15
4.01
2.04
2.7
2.3
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
6
15
4.01
2.04
1.8
2.5
—
—
—
0
0
(3048879) Bone marrow aspiration report
8
26
3.09
2.01
1.4
1.9
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
21
111
1.91
2.01
3.0
3.6
%
58.3
55.5
0.17
11
72
(3013139) Helicobacter pylori Ag [Presence] in Stool
88
659
1.36
1.98
1.2
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
12
51
2.36
1.95
5.6
3.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
9
33
2.74
1.93
1.4
1.7
—
—
—
0
0
(4015189)
7
22
3.19
1.88
4.9
1.9
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
23
129
1.80
1.86
1.7
1.6
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
19
102
1.87
1.76
1.4
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
14
67
2.10
1.76
1.6
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
18
95
1.91
1.75
1.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
5
13
3.86
1.71
1.4
1.4
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
6
19
3.17
1.66
1.0
1.1
u/ml
4.0
0.8
—
6
10
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
6
19
3.17
1.66
1.2
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
7
25
2.81
1.65
2.7
1.8
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
12
57
2.11
1.55
1.0
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
34
224
1.53
1.55
1.4
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
10
44
2.28
1.53
1.3
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
10
44
2.28
1.53
1.3
1.4
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
17
93
1.84
1.52
1.0
1.0
mg/l
313.2
275.7
1.17
17
85
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
317
2825
1.16
1.50
1.8
1.6
mmol/l
1.3
1.4
0.58
276
2381
(3025130) Human papilloma virus identified in Specimen
15
79
1.91
1.49
2.1
1.6
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
14
72
1.95
1.49
1.1
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
13
65
2.01
1.49
1.2
1.2
—
—
—
0
0
(4034850)
22
353
0.62
1.46
18.0
8.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
11
52
2.12
1.44
1.3
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
11
52
2.12
1.44
1.3
1.4
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
14
73
1.93
1.44
1.1
1.1
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
5
16
3.13
1.44
2.0
2.4
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
16
3.13
1.44
1.0
1.1
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
18
103
1.76
1.41
1.1
1.0
u/ml
1.2
4.8
—
10
35
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
36
246
1.48
1.41
1.2
1.3
miu/ml
342.8
215.8
—
9
109
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
21
126
1.68
1.40
1.0
1.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
72
922
0.77
1.38
1.8
1.8
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
122
0.41
1.37
1.0
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
122
0.41
1.37
1.0
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
122
0.41
1.37
1.0
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
122
0.41
1.37
1.0
1.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
9
41
2.20
1.37
1.0
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
6
23
2.62
1.37
1.0
1.2
—
—
—
0
0
(4198724)
9
42
2.15
1.33
6.4
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
7
148
0.47
1.32
1.3
1.4
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
5
18
2.78
1.28
4.4
2.3
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
11
55
2.01
1.27
1.3
1.1
u/l
104.3
91.1
0.23
11
41
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
11
55
2.01
1.27
1.3
1.1
u/l
34.6
34.3
0.01
11
40
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
61
467
1.32
1.27
1.0
1.1
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
38
274
1.40
1.16
1.1
1.5
u/l
11.3
8.1
0.54
28
228
(3034988) Calcium [Moles/volume] in Capillary blood
5
20
2.51
1.15
13.4
1.5
mmol/l
1.1
1.2
—
5
20
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
46
606
0.75
1.12
1.4
1.4
—
—
—
0
0
(44813793)
11
58
1.90
1.12
1.0
1.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
124
1052
1.20
1.10
1.5
1.6
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
7
32
2.19
1.08
2.3
2.9
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
349
3791
0.89
1.05
3.4
2.8
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
6
124
0.48
1.05
1.2
1.5
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
9
48
1.88
1.00
3.6
3.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
44
335
1.32
0.99
1.1
1.1
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
7
36
1.95
0.97
1.3
1.2
g/l
0.3
0.3
—
7
30
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
9
50
1.81
0.96
1.6
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
521
4905
1.10
0.96
4.6
5.0
ug/l
2.1
3.5
1.02
468
4417
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
149
1302
1.16
0.95
12.5
5.7
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
7
37
1.90
0.94
1.6
1.4
umol/l
2.8
2.0
—
7
32
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
26
183
1.43
0.94
2.3
2.3
u/l
20448.9
2852.0
—
7
68
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
102
0.49
0.89
1.2
1.5
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
8
43
1.87
0.87
1.1
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
6
30
2.00
0.87
1.5
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
24
170
1.42
0.85
1.8
1.6
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
17
112
1.52
0.85
1.2
1.0
u/ml
9.0
3.1
—
10
39
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
13
80
1.63
0.84
1.5
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
14
215
0.65
0.84
1.3
1.5
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
6
33
1.82
0.79
1.3
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
98
0.51
0.78
1.0
1.0
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
125
1099
1.15
0.77
2.4
2.2
nmol/l
12.9
13.3
0.18
109
979
(3028707) Methadone [Presence] in Urine by Screen method
21
149
1.42
0.75
4.5
3.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
27
201
1.35
0.74
1.3
1.3
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
5
24
2.09
0.74
1.0
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
9
54
1.67
0.74
1.0
1.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
14
92
1.53
0.72
2.1
1.7
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
5
27
1.85
0.68
12.4
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
5
27
1.85
0.68
1.2
1.2
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
7
43
1.63
0.67
1.1
1.1
—
7.3
—
0
7
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
147
1322
1.13
0.66
1.8
1.8
%
1.6
1.5
0.35
122
1168
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
11
70
1.58
0.65
1.9
1.5
g/l
1.2
1.0
0.45
11
70
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
10
62
1.62
0.65
1.0
1.1
nmol/l
7.9
5.0
—
5
10
(3039443) Prostate specific Ag panel - Serum or Plasma
22
291
0.75
0.63
1.5
1.7
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
17
122
1.40
0.60
9.1
3.7
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
25
192
1.31
0.59
1.5
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
10
64
1.57
0.58
1.8
1.6
—
—
—
0
0
(44806420)
6
35
1.72
0.57
2.0
2.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
96
850
1.14
0.57
1.4
1.4
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
36
292
1.24
0.57
1.3
1.5
iu/l
21.5
24.5
0.25
29
253
(3051387) C reactive protein [Mass/volume] in Capillary blood
31
248
1.26
0.55
5.3
3.1
mg/l
17.7
27.4
1.68
20
147
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
18
133
1.36
0.55
1.6
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
18
133
1.36
0.55
1.6
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
18
133
1.36
0.55
1.6
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
18
133
1.36
0.55
1.6
1.3
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
47
395
1.20
0.54
1.6
1.7
nmol/l
38.1
39.6
0.25
47
380
(3005988) Vibrio sp identified in Specimen by Organism specific culture
18
134
1.35
0.53
1.6
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
18
134
1.35
0.53
1.6
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
53
453
1.18
0.51
2.3
2.8
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
96
858
1.13
0.51
1.8
2.0
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
7
46
1.52
0.48
1.0
1.1
—
412.9
—
0
12
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
7
49
1.43
0.46
1.1
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
7
49
1.43
0.46
1.1
2.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
16
207
0.77
0.42
1.4
1.4
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
8
57
1.41
0.42
1.1
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
8
58
1.38
0.41
1.1
1.8
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
7
101
0.69
0.39
1.3
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
14
182
0.77
0.39
1.1
1.3
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
35
1.43
0.39
1.2
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
86
784
1.10
0.36
1.8
1.9
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
5
78
0.64
0.35
21.4
19.5
nmol/l
1403.8
1392.8
—
5
78
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
6
42
1.43
0.35
1.3
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
30
349
0.86
0.32
2.1
1.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
111
1031
1.08
0.32
1.5
1.4
—
—
—
0
0
(4281824)
11
84
1.31
0.30
1.2
1.1
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
12
93
1.29
0.30
4.7
3.4
mg/l
21.1
16.8
0.18
12
75
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
57
1.23
0.29
1.0
1.1
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
11
85
1.30
0.28
1.1
1.3
mmol/l
1.7
1.9
0.55
11
80
(3016018) Differential panel - Cerebral spinal fluid
9
118
0.76
0.27
1.1
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
25
215
1.17
0.26
1.3
1.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
26
225
1.16
0.26
1.2
1.6
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
75
0.67
0.26
1.0
1.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
9
75
1.20
0.25
1.2
1.6
—
—
—
0
0
(4024509)
9
77
1.17
0.24
1.6
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
31
274
1.13
0.24
3.3
2.2
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
16
134
1.20
0.23
1.1
1.0
u/ml
3.8
2.4
—
7
60
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
28
316
0.88
0.22
2.8
1.8
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
7
94
0.74
0.22
1.1
1.6
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
41
1.22
0.22
1.2
1.1
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
30
334
0.90
0.20
1.2
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
32
353
0.90
0.18
3.4
2.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
32
352
0.91
0.18
3.4
2.3
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
7
59
1.19
0.18
22.0
9.5
mmol/l
0.5
0.6
—
7
53
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
59
1.19
0.18
1.0
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
13
110
1.18
0.17
1.2
1.6
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
15
129
1.16
0.17
1.5
1.3
mmol/l
8.0
7.4
—
8
93
(3027944) Amphetamines [Presence] in Urine
32
350
0.91
0.16
3.1
2.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
405
3976
1.03
0.16
4.0
4.3
%
22.8
21.5
0.75
186
1983
(3000764) Benzodiazepines [Presence] in Urine
32
349
0.91
0.15
3.4
2.3
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
9
78
1.15
0.15
3.9
2.2
nmol/l
14.7
19.4
—
9
72
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
7
90
0.78
0.14
1.1
1.7
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
296
2899
1.03
0.14
2.7
3.0
ug/l
0.8
0.8
0.10
199
1921
(3023511) Choriogonadotropin [Units/volume] in Urine
12
103
1.17
0.13
2.0
1.3
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
22
242
0.91
0.13
1.1
1.6
e6/l
5.8
20.5
0.57
17
189
(3011288) Drugs identified in Urine by Screen method
25
229
1.09
0.12
4.2
3.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
42
444
0.94
0.10
1.7
1.6
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
13
115
1.13
0.10
1.4
1.8
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
46
1.09
0.09
1.2
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
31
330
0.94
0.09
3.5
2.3
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
6
55
1.09
0.09
1.2
1.4
nmol/l
1.0
1.2
—
6
42
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
137
1339
1.03
0.08
4.8
4.5
%
33.0
32.0
0.47
105
852
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
6
57
1.05
0.08
1.2
1.6
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
5
63
0.79
0.08
1.0
1.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
38
399
0.95
0.08
2.3
1.9
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
6
71
0.84
0.07
1.3
1.5
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
7
80
0.87
0.07
2.3
1.4
—
74.0
—
0
8
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
40
383
1.05
0.07
3.1
1.4
mg/l
5.0
3.1
0.47
28
286
(4146454)
12
129
0.93
0.03
2.8
2.6
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
11
107
1.03
0.00
1.5
1.4
pmol/l
98.8
67.4
—
6
35
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40758358) Immune stain study
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
6.2
—
0
9
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003721) Smooth muscle Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
2.2
—
0
5
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
52
0.96
0.00
3.6
7.1
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
7
75
0.93
0.00
1.4
2.2
umol/l
8.3
4.8
—
7
51
(3010937) Rubella virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(4038314)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.7
—
370.3
—
0
6
(4212803)
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.2
—
93.2
—
0
6
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3019298) Eosinophils/100 leukocytes in Peritoneal fluid
0
5
0.00
0.00
0.0
1.0
—
0.2
—
0
5
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013762) Body weight Measured
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
16.9
—
0
7
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
5
0.00
0.00
0.0
1.8
—
1.4
—
0
5
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint I9_PERICARD and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_PERICARD | 2.435 [2.09, 2.83] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.073 |
During the follow-up period (1.1.1998 — 31.12.2019), 816 out of 2298 females with I9_PERICARD died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_PERICARD | 1.709 [1.5, 1.94] | < 0.001 |
| Birth year | 0.991 [0.98, 1.0] | 0.041 |
During the follow-up period (1.1.1998 — 31.12.2019), 844 out of 3737 males with I9_PERICARD died.
Mortality risk
Mortality risk for people of age
years, who have I9_PERICARD.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.234% | 0.323% |
| 5 | 1.469% | 2.054% |
| 10 | 3.199% | 5.322% |
| 15 | 6.159% | 10.534% |
| 20 | 10.517% | 17.41% |
Relationships between endpoints
↥Index endpoint: I9_PERICARD – Pericarditis
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data